FDA halts gene therapy trials after brain tumor found in patient One of the impacted rare-disease treatments, for MPS II, had been nearing potential approval By Jason MastJan. 28, 2026 General Assignment Reporter

https://www.statnews.com/2026/01/28/fda-halts-regenxbio-gene-therapy-trials/